A new chapter in immune checkpoint inhibitor therapy: starting with advanced lung squamous cell carcinoma.

ABSTRACT:

SUBMITTER: Fei K 

PROVIDER: S-EPMC7354157 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature